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Background: Poor adherence to antiretroviral therapy negatively affects the suppression of viral replication. It
increases risks of drug resistance, treatment failure, Acquired Immuno Deficiency Syndrome (AIDS)-related morbidity
and mortality among children. This study assessed the level of adherence to antiretroviral therapy and its associated
factors among children at hospitals in South Wollo Zone, Northeast Ethiopia.
Methods: An institution-based cross-sectional study was conducted among Human Immunodeficiency Virus
(HIV)-infected children in April 2013. A total of 464 children who were taking Antiretroviral Therapy (ART) in the
hospitals were included. Data were collected using pretested and structured questionnaires using a face-to-face
interview method. Descriptive and summary statistics were employed. Bivariate and multiple logistic regressions
were computed. Odds ratios and their 95% confidence intervals were computed to determine the level of
significance.
Results: Of the 464 study samples, 440 children with their caregivers were included in the final analysis. A total of
78.6% of the caregivers reported that their children were adherent to antiretroviral therapy in the month prior to
the interview. Caregivers' knowledge about antiretroviral treatment [AOR = 2.72(95% CI: 1.82, 5.39)], no current
substance use of the caregivers [Adjusted Odds Ratio (AOR) = 2.21(95% Confidence Interval (CI): 1.34, 7.13)],
proximity to the health care facility [AOR = 2.31(95% CI: 1.94, 4.63)], if the child knows HIV-positive status [AOR = 3.47
(95% CI: 2.10, 6.81)] and caregiver’s educational status [AOR = 0.59(95% CI: 0.21, 0.82)] were significantly and
independently associated with adherence of children to antiretroviral therapy.
Conclusion: Adherence of antiretroviral therapy in this study was comparable to other studies conducted in
developing countries. Caregiver’s knowledge about antiretroviral therapy, no current use of substances, close
proximity to health facilities, and letting child’s know his/her HIV status improves adherence to antiretroviral
therapy. Health care providers should educate caregivers about antiretroviral therapy and encourage HIV positive
status disclosure to the child.
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Globally, of the estimated 34 million people living with
HIV in 2011, 3.3 million were children under the age of
15 years. More than 90cph of these children were residing
in sub-Saharan Africa [1]. In 2010, Ethiopia had 1,216,908
people living with HIV of which 79,875 (6.5%) were chil-
dren [2]. Antiretroviral Therapy (ART) improves the prog-
nosis of HIV-infected individuals, reduces HIV-related
morbidity and mortality, and reduces other opportunistic
infections [3-5].
Inadequate adherence increases the risk of drug resist-
ance and treatment failure [6]. Therefore, optimum ad-
herence is essential for sustainable success of ART [7].
Suboptimal adherence among children is common in both
developed and developing countries [8]. Taking ≥ 95% of
prescribed doses is recommended for optimal virologic
suppression and minimizes the rate of treatment failure
[6,9] and decreases risk of virologic failure by more than
50% [10].
Adherence is a serious challenge for those receiving
ART especially children. Factors associated with paediat-
ric ART adherence can be related to caregivers, children
themselves, the medication/regimen, socioeconomic, or
service delivery issues [11-14].
Unlike adults, young children rely upon their caregivers
for their medicines. However, these caregivers may also be
ill [14]. In addition, children may not be able to take pills
and syrup formulations because of the large size of tablets
and poor palatability of syrups [15,16]. Furthermore, par-
ents may have a poor understanding of the need to take
the medication and they may be unwilling to disclose the
child’s HIV-positive status to the child or others involved
in the care. This may create problems in administering
doses while the parent is at work or the child at school
(9). HIV develops resistance if the concentration of drugs
in the blood is low. Hence, optimal adherence to ART is
essential to ensure high level of drugs by taking medica-
tion correctly and consistently (10).
As a result, the guideline for paediatric HIV care and
treatment in Ethiopia recommends at least two adherence
sessions which include caregiver education and counseling
before ART initiation. The same guideline also recom-
mends adherence reinforcement at each follow-up visit.
Moreover, the limited availability of second-line therapy in
resource-limited settings like Ethiopia emphasizes the im-
portance of adherence and preservation of first-line regi-
mens. Therefore, assessment and support of adherence is
fundamental to successful antiretroviral therapy and pre-
vention of drug resistance [6]. The findings of this study
are particularly helpful to those clinicians who work with
paediatric HIV positive patients in third world countries.
Hence, this study assessed the level of adherence to ART
and associated factors among children at hospitals in
South Wollo Zone, Northeast Ethiopia.Methods
A facility-based cross-sectional study was conducted in
April 2013 at paediatric ART clinics in the three hospitals
(Dessie Referral Hospital, Borumeda District Hospital, and
Hidar 11 District Hospital) that provide ART services in
South Wollo Zone, Northeast Ethiopia. These three hospi-
tals provide services to about 15,000, 1,600 and 2,500 cli-
ents living with HIV registered at chronic care follow-up
clinics (treated and untreated), respectively. There were
1210 children on chronic HIV care and support follow up
at the three hospitals (900 at Dessie, 130 at Borumeda, and
180 at Hidar-11 hospitals). Of these 1210 children, 464
(324 at Dessie, 58 at Borumeda, and 82 at Hidar-11 hospi-
tals) were on ART. Each hospital has its own case man-
agers, adherence supporters, support groups for mothers,
and data clerks. Children aged 2 months to 14 years and
who were receiving ART for at least one month were in-
cluded in the study.
The sample size was calculated by considering the as-
sumptions for single population proportion formula: the
proportion (P) =80.9% of adherence rate in Northwest
Ethiopia [17], Z = standard normal distribution value at
95% confidence level of Za/2 = 1.96, 5% of absolute pre-
cision, and 10% non-response rate. Hence, the total sam-
ple size was 263. However, there were 464 children who
were taking ART in these hospitals and therefore, all
were included.
Pretested and structured questionnaires using face-to-face
interviewing with caregivers were used for data collection.
The questionnaire was partly adapted from the AIDS
Clinical Trial Group (ACTG) adherence follow-up ques-
tionnaire [18] and review of similar literature. Pre-testing of
the questionnaire was undertaken on 24 caregivers at the
Dessie Health Center before the actual data collection.
Medical records were reviewed to collect clinical data such
as WHO clinical stage and the CD4 count of children. Adher-
ence was measured by the caregivers’ report of a one-month
recall of missed doses prior to the date of the interview.
Data were collected by five diploma nurses (supervised
by three B.Sc nurses). A two days comprehensive training
was given to data collectors and supervisors. The ques-
tionnaire was first prepared in English and then translated
into Amharic (the local language), and back into English
to ensure consistency.
The questionnaires were coded and entered into EPI
Info version 3.5.3 statistical software and then exported to
SPSS windows version 16 for further analysis. Data were
summarized and presented using descriptive statistics. Bi-
variate and multiple logistic regressions were computed to
identify the presence and strength of associations. Odds
ratios with 95% CI were computed and variables having
p-values less than 0.05 in the multiple logistic regression
models were considered significantly associated with the
dependent variable (adherence).
Table 1 Socio-demographic characteristics of the study
participants at South Wollo Zone hospitals, Northeast






















Orthodox Christian 182 41.4
Protestant 13 3.0
Educational status of the caregiver
Can’t read and write 223 50.7
Primary school(1–8 grade) 116 26.4
Secondary or above 101 23.0
Substance use of caregivers
User 44 10.0
Non-user 396 90.0






House wife 90 20.5
Farmer 165 37.5
Government employee 65 14.8
Other** 14 3.2




Table 1 Socio-demographic characteristics of the study
participants at South Wollo Zone hospitals, Northeast





Biological parents 343 78.0
Other relatives and guardian 97 22.1
WHO Clinical stage
Stage I 60 13.6
Stage II 214 48.6
Stage III 161 36.6









*Gurage, Afar **Students, daily laborers.
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Adherence to ART in this study was when the children
took ≥95% of the prescribed doses in the month prior to
the interview. Non- adherence to ART was when the child
took less than 95% of the total doses or missed more than
3 doses in the month prior to the interview. In addition, if
a child missed a single dose in the past three and seven
days, it was considered non-adherent.
Knowledge about ART was categorised by asking eight
questions. Those respondents who scored greater than
or equal to the mean for the knowledge questions were
considered as knowledgeable, otherwise not.
Attitude about ART was categorised based on five ques-
tions using a Likert scale method and the mean scores
were computed and then dichotomized into favourable
(score ≥mean value) or unfavourable (score <mean value).
Ethical considerations
Ethical clearance was obtained from the Ethical Review
Committee of the College of Medicine and Health Sci-
ences, University of Gondar. An official letter of cooper-
ation was granted to the administrative offices of the
three hospitals. Verbal informed consent was obtained
from each participant before the start of the interview.
Due to the high illiteracy, it was considered impractical
to obtain written consent from each study participant.
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seven years and were aware of their sero-postive status.
All interviews were conducted in a private room and
confidentiality was insured.Results
Socio-demographic and clinical characteristics of the
study participants
Of the 464 study participants, 440 children along with
their caregivers were included in the analysis, yielding a
response rate of 94.8%. With the twenty-four excluded
cases, eighteen caregivers did not know the dosing his-
tory for the past month and six questionnaires were dis-
carded for being incomplete. Two hundred eighty one
(63.9%) of the caregivers were females. The mean age of
the children was 9.4 years (SD = 5.13) and 54.8% of them
were between the ages of 10–14 years. Half (50.7%) of
the caregivers were unable to read and write. Two hun-
dred and fourteen (48.6%) of the children were at WHO
clinical stage II. One hundred fifty-nine (36.1%) children
had a CD4 count of <200 cells/mm3 at ART initiation
and 56% had a current CD4 count of ≥500 cells/mm3
(Table 1).Knowledge and attitude about ART treatment
Two-thirds (67%) of the participants knew about ART be-
fore their child was diagnosed. The majority (90%) of the
respondents were knowledgeable and had a favourable at-
titude towards ART. Three hundred sixty-two (82.3%)
participants reported that taking ART incorrectly would
result in resistance to the drugs.Adherence to ART among children
Based on the caregivers’ report, a total of 78.6% (95% CI:
74.8%, 82.4%) children were reported to have an adher-
ence rate of ≥95% in the month prior to interview. The
adherence rates to ART among children in the past three







Taste of the drugs
Illness of the child
Side effects of drugs
Pill burden
Illness of the caregivers
Run out of pills
Transportation problem
Child's refusal to take the drugs
Forgetfullness
Others
Figure 1 Reasons for non-adherence to ART among children at SouthReasons for non-adherence
The commonly mentioned reasons for missing these
medications were: forgetfulness (28.4%), child’s refusal to
take the drugs (19.3%); and lack of transportation access
to the facilities (19.1%) (Figure 1).
Factors associated with adherence to ART among children
In multiple logistic regression analysis, current substance
use of the caregivers, disclosure of HIV status to the
child, knowledge of caregivers about ART treatment,
distance from the health facility, and educational status
of secondary schooling or above of the caregivers, and
current CD4 count of 500 or more were significantly
and independently associated with adherence.
Children whose caregivers were not currently using
substances were 2.2 times more likely to be adherent to
ART than those whose caregivers used substances like
alcohol, chat and/or cigarettes [AOR = 2.21(95% CI: 1.94,
5.39)]. Children who knew their HIV status (disclosed)
were 3.6 times more likely to be adherent than their
counterparts [AOR = 3.47(95% CI: 2.10, 6.81)].
The present study also showed that children who came
from a distance of less than 10 km were 2.3 times more
likely to be adherent to ART compared to those who came
from 10 km or above [AOR = 2.31(95% CI: 1.94, 4.63)].
If the caregiver was knowledgeable about ART treat-
ment, the child was 2.7 times more likely to be adherent
to ART [AOR= 2.72(95% CI: 1.82, 7.13)]. Those children
whose caregivers had secondary or above educational sta-
tus were 0.41% less likely to be adherent than those chil-
dren with caregivers who did not read and write [AOR =
0.59(95% CI: 0.21, 0.83)]. Those children whose current
CD4 count of 500 or greater were 1.89 times more likely
to be adherent than those children with CD4 count less
than 500 [AOR = 1.89(95% CI:1.34, 3.87)] (Table 2).
Discussion
This study assessed the rate of antiretroviral therapy ad-
herence and its associated factors among children at
South Wollo Zone Hospitals, Northeast Ethiopia. The





Wollo Zone Hospitals, Northeast Ethiopia, 2013.
Table 2 Crude and adjusted odds ratios (OR) and 95% confidence intervals (CI) of determinants adherence to HAART
at South Wollo Zone hospitals, Northeast Ethiopia, 2013 (n = 440)
Variables Adherence status OR (95% CI)
Adherent Non- adherent COR(95% CI) P value AOR(95% CI) P-value
Sex of the caregivers 0.145
Male 119 40 1
Female 227 54 1.4(0.88, 2.25)
Age of the caregivers 0.16
<30 106 28 1
31-40 133 29 1.29(0.73, 4.07)
≥41 102 33 0.49(0.31, 2.51)
Educational status of the caregivers 0.022 0.031
Can’t read and write 175 48 1 1
Elementary school 97 19 1.4(0.77,2.52) 1.23(0.32, 2.66)
Secondary or above 74 27 0.75(0.43,1.29) 0.59(0.21,0.83)*
Substance use of the caregivers* 0.033 0.008
Used 29 15 1 1
Not used 317 79 2.07(1.07,4.05) 2.21(1.34,5.39)*
Caregivers knowledge about ART 0.004 0.023
Knowledgeable 320 77 2.71(1.40, 5.25) 2.72(1.82, 7.13)*
Non knowledgeable 26 17 1 1
Attitude of caregivers towards ART 0.030
Favourable 294 88 0.38( 0.28, 6.24)
Unfavourable 52 6 1
Taking medication besides ART
Yes 26 4 1
No 320 90 0.54(0.52,5.37)
Distance from the health facility 0.001 0.003
<10Km 246 45 2.6(1.68,4.22) 2.31(1.94, 4. 63)*
≥10Km 100 49 1 1
Disclosure of HIV status 0.041 0.029
Yes 216 28 3.9(2.39,6.4) 3.47(2.10, 6.81)*
No 130 66 1 1
CD4 count at the start of treatment 0.18
<200 118 41 1
200-499 179 45 1.3(0.85, 2.25)
≥500 49 8 2.12(0.93,4.87)
Getting support
Yes 73 11 2.01(1.02,3.98)
No 273 83 1
Current CD4 count 0.03 0.022
<500 139 54 1 1
≥500 207 40 2.01(1.27, 3.19) 1.89(1.34, 3.87)*
*p value < 0.05.
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finding is comparable to similar studies conducted in
Ethiopia (80.9%) [17], Nigeria (80%) [19], Togo (80%)
[20], and Vietnam (75.1%) [21].
This finding is also comparable with a systematic re-
view of paediatric ART adherence studies in middle- and
low-income countries (75%) [22]. Nevertheless, it was
lower than studies conducted in the United States (84%)
[22], Jamaica (87.5%) [23], New Delhi (91.4%) [24] but
higher than studies conducted in Brazil (50.5%) [25], and
Kenya (44.2%) [26].
In the present study, caregivers’ forgetfulness was re-
ported as the major reason (28.4%) for missing doses.
Studies conducted in Brazil, Kenya, and Nigeria [25-27]
supported this finding. This could be due to the care-
givers being busy with their daily routines which, in
turn, lead the caregivers to easily forget to administer
the pills as prescribed. Similar to other studies [28-30],
child refusal to take medication (19.3%) and lack of
transport access to reach facilities (19%) lead them to
miss doses.
A number of factors were reported as predictors of ad-
herence among children on ART. In the present study, if
the caregiver uses substances then the child was less
likely to be adherent to ART. A studies conducted in
Vietnam [21], Nepal [30], and South Africa [31] showed
similar findings. This might be due to substance use
could lead them to forget administration of the drugs.
Forgetfulness is one of the reasons for missing doses in
children as shown by this study (28.4%).
The findings also showed that those children who have
been disclosed of their HIV status were about four times
more likely to be adherent to ART than those who had
not been disclosed of their HIV status. This finding is
supported in studies conducted at Uganda [32] and
Democratic Republic of Congo [16]. This may be seen
from two overlapping, yet separate, angles. Firstly, chil-
dren who knew they are HIV-positive status can be more
concerned on their health and could aware that these
drugs are helpful. Secondly, nondisclosed children might
not understand the rationale behind taking drugs and
become resistant to take them as they fail to understand
why they take medicine while feeling apparently healthy.
This study also showed that children’s adherence to
ART is associated with distance from the health facilities
which is in line with findings from Ethiopia [28], Nepal
[30], and South Africa [31]. This could happen because
the clients miss appointments due to difficulties in
reaching the treatment centres. Lack of transportation,
long traveling distance, and geographical inaccessibilities
might be the reasons.
In the present study, caregivers knowledge about ART
treatment was associated with the child’s adherence to
ART. This finding is consistent with that of a studyconducted in Addis Ababa [28]. If caregivers do not
understand benefits of ART to children, they might be
poor motivated to administer drugs timely and regularly.
Unlike other studies [30,33], in this study educational
status of caregiver was negatively associated with adher-
ence to ART. Children whose caregivers had secondary
and above education were less likely to adhere to ART
compared to children whose caregivers were not able to
read and write. This could be explained by the idea that
these caregivers were more likely employed and thus
spend less time with the child to administer the drugs
consistently or forget doing so amidst busy days.
In the present study, children whose current CD4 count
of 500 or greater were about two times more likely to be
adherent than those children with CD4 count less than
500. It could be surmised that long-term adherence leads
to higher CD4 counts i.e. CD4 increases as a result of
optimal adherence to ART.
However, the present study does have some inherent
limitations. Due to financial constraints, adherence was
assessed through a self-reporting adherence question-
naire instead of other more objective tools. Caregivers’
reports might lead to overestimated adherence. Though
efforts made during data collection to minimize the so-
cial desirability and recall biases, these may not be elimi-
nated. This study did not assess the adherence related to
the correct timing for ART drug administration. The
cross-sectional nature of the study which used a snap-
shot of adherence at one point in time may hinder the
accuracy of adherence.
Conclusion
Adherence to ART in the study area was comparable to
other studies conducted in developing countries. The
caregiver’s knowledge about ART, non-usage of sub-
stances, proximity to health facilities, and disclosing the
child’s HIV status were associated with adherence to
ART. Health care providers should educate caregivers
about ART and avoidance of substance use. Further at-
tempts are also needed to encourage caregivers to dis-
close the HIV status to the children.
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